RVTY
Revvity, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow +13.2% ·
net new positions -8.3%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +9 | 65.85M | $7.33B | +14 | −6 |
| Q1 2026 | 126 | -7 | 72.99M | $6.39B | +4 | −12 |
| Q4 2025 | 133 | 0 | 75.39M | $7.30B | +3 | −2 |
| Q3 2025 | 19 | +1 | 44.69M | $3.92B | +1 | −1 |
| Q2 2025 | 16 | +1 | 42.02M | $4.06B | +3 | −2 |
| Q1 2025 | 12 | -1 | 20.50M | $2.17B | n/a | −1 |
| Q4 2024 | 13 | 0 | 18.11M | $2.02B | +1 | −1 |
| Q3 2024 | 12 | -1 | 11.86M | $1.51B | +1 | −2 |
| Q2 2024 | 13 | n/a | 11.86M | $1.24B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.56M | +25.3% | $1.01B | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 5.17M | 0.0% | $546.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 2.99M | +3.2% | $315.67M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 1.24M | +8.4% | $131.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | PRIMECAP Management ✦ | 1.15M | +20.4% | $121.20M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 111.09K | +187.1% | $11.75M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Gotham Asset Management ✦ | 108.35K | -33.8% | $11.46M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | Millennium Management ✦ | 69.40K | +102.0% | $7.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 62.02K | +8.3% | $6.56M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 22.54K | +238.7% | $2.38M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 8.45K | +5.2% | $882,549 | 0.0% | ▲ Add | 4 | SEC ↗ ×4 |
| 12 | Marshall Wace ✦ | 2.92K | -17.9% | $308,936 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $455,480 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 495 holders, 115.11M shares, $7.19B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 1.63K sh · $235,728
Officer · 7.33K sh · $1.03M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology